Featured Suppliers:

Sponsored Links


 

Lilly, Eli, & Co


News and Blogs

Total : 174 View more »

Makarem Associates Files Wrongful Death Lawsuit Against Eli Lilly For Its Drug Zyprexa

www.prlog.org

Makarem & Associates Files Wrongful Death Lawsuit Against Eli Lilly For Its Drug Zyprexa. Makarem & Associates files lawsuit charging drug manufacturer Eli Lilly with wrongful death of 20 year old Cody Tadai who was prescribed Zyprexa®, a prescription drug used to treat schizophrenia and bipolar

http://www.prlog.org/10395248-makarem-associates-files-wrongful-death-lawsuit-against-eli-lilly-for-its-drug-zyprexa.html

Byetta approved as first-line treatment for Type 2 diabetes

www.drugstorenews.com | Nov 2, 2009

The Food and Drug Administration has approved a diabetes drug as a first-line treatment for the disease.

http://www.drugstorenews.com/story.aspx?id=121043

Novo Nordisk Diabetes Drug May Aid Weight Loss

www.cnbc.com

A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.

http://www.cnbc.com//id/33438514

 

VIDEO from Medialink and Eli Lilly and Company: Award-winning Diabetes Documentary to Make World TV

The award-winning documentary Life for a Child will make its world television debut on the Sundance Channel on World Diabetes Day - Nov. 14, 2009, at 8 p.m. EST/PST. Directed by Academy Award(R) nominee Edward Lachman, the film follows the journeys of children with type 1 diabetes amid the verdant mountains and swarming streets of Nepal, one the world's poorest countries. The children are supported with life-saving medication and care by the International Diabetes Federation's (IDF) Life for a Child Program.

See video from Eli Lilly and Company at: http://inr.mediaseed.tv/LillyChild_37063/

The Life for a Child film was produced by IDF, the world's leading diabetes advocacy organization, and Eli Lilly and Company, a global leader in diabetes treatment, to raise awareness of the devastating impact of diabetes and increase support for the Life for a Child Program. It will be presented in association with the Juvenile Diabetes Research Foundation (JDRF), the world's largest charitable funder of type 1 diabetes research.

Life for a Child premiered in competition at the prestigious Tribeca Film Festival in New York in April 2008 and made its European Premiere at the Vienna International Film Festival in the fall of 2008. In March 2009, it was honored as Best Documentary Short at the Cinequest Film Festival in California, and has been screened in more than a dozen countries and six festivals.

One of the world's most celebrated cinematographers, Lachman was nominated for an Oscar for cinematography in 2003 for Far From Heaven with Julianne Moore, and has photographed dozens of studio and independent features and documentaries, including Erin Brockovich, A Prairie Home Companion and a historic documentary on Mother Theresa.

"I wanted to tell the stories of families who are dealing with the daily struggles of life but then also have to deal with the challenges of diabetes," said Lachman, who directed Life for a Child following work on the critically-acclaimed 2007 feature film I'm Not There, starring Cate Blanchett and Heath Ledger.

Medialink is a division of The NewsMarket. Registered journalists can access video, audio, text, graphics and photos at http://www.thenewsmarket.com.

10NY09-0063

SOURCE Medialink; Eli Lilly and Company

http://www.thenewsmarket.com

Read more...

Tags: california   children   diabetes   film   foundation   graphics   nepal   new_york   research   studio   video  

Companies: Eli Lilly & Co. (LLY)

 

GeneNews signs agreement with Eli Lilly and Company - Zibb.com

GeneNews Limited, a Canada-based molecular diagnostics company, has entered into an agreement with Eli Lilly and Company, under which Eli Lilly would have a selective access to research from its osteoarthritis genomic biomarker program. Eli Lilly is a US-based pharmaceutical company.

Deal Type    Partnership
Sub-Category Licensing Agreement
Deal Status  Announced: 2009-10-27

Deal Participants

Partner 1 (Company) Eli Lilly and Company
Partner 2 (Company) GeneNews Limited

Read more...

Tags: canada   partnership   pharmaceuticals   research  

Companies: Eli Lilly & Co. (LLY), GeneNews Ltd (GNWSF)

 

Eli Lilly Net Income Rises 22% with Improved Gross Margins, Guides Higher (LLY) - Zibb.com

10/21/2009-Eli Lilly (NYSE:LLY) reported Q3 EPS $1.20, topping consensus estimates of $1.02. Revenues in the quarter rose 7% year-over-year to $5.56 billion, and came in ahead of consensus estimates of $5.41 billion. Lilly said gross margin as a percent of total revenue increased by 3.3 percentage points, to 81.1 percent. The company adjusted its full-year 2009 estimates, now projecting EPS of $4.30 - $4.40 (vs. consensus estimates of $4.29).

"Lilly continues to deliver very solid financial results," said John C. Lechleiter Ph.D., Lilly's chairman and chief executive officer. "Our performance in the third quarter once again was driven by volume-based sales growth, improving gross margins and tight control of operating expenses, allowing us to deliver very attractive earnings growth. These results are evidence of the strength of our current operations as we implement our new operating model, streamline our organization and take measures to accelerate the flow of new medicines through our pipeline."

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Read more...

Tags: ceo   earnings   eps   market   nyse   pipeline   revenue   sales   securities  

Companies: Eli Lilly & Co. (LLY)

 

Eli Lilly to pay S. Carolina $45 million - Zibb.com

Eli Lilly has agreed to pay South Carolina a record $45 million to settle a dispute over the marketing of the anti-psychotic drug Zyprexa, officials say.

"We think that putting the issue behind us is not only in the best of interest of Eli Lilly, but also the patients and physicians who count on Zyprexa as a life-saving drug every day," Eli Lilly spokeswoman Mary Lemons told The (Columbia, S.C.) State in a story published Saturday.

South Carolina was one of 45 states that sued the Indianapolis drug company for false marketing.

While Zyprexa is approved only for the treatment of schizophrenia and bipolar disorder, Eli Lilly allegedly urged doctors to prescribe it for depression, dementia and attention deficit disorder, South Carolina Attorney General Henry McMaster said Friday.

The $45 million will repay South Carolina the millions spent by state health plans for the drug, and to treat its side effects, in the nearly 64,000 South Carolina patients who used the drug from 1996 to 2007, McMaster said.

www.upi.com

Read more...

Tags: deficit   depression   doctors   marketing   physicians   south carolina  

Companies: Eli Lilly & Co. (LLY)

 

Web Sites

Total : 574 View more »

Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation

www.bio-medicine.org

...SAN DIEGO Oct. 29 /- As part of its strategy t... We are moving full speed ahead toward building a biotechnology powerh...Lilly's latest biotechnology center is located within an extensive hub...Of the nearly 200 scientists based at the center more than half are

http://www.bio-medicine.org/medicine-technology-1/Eli-Lilly-and-Company-Opens-Eco-Friendly-Biotechnology-Center-on-the-West-Coast-Designed-to-Speed-and-Enhance-Innovation-5848-1/

Welcome to Lilly

maple leaf Eli Lilly Canada Inc. Welcome to Eli Lilly Canada Bienvenue chez Eli Lilly Canada Copyright © 2008 Eli Lilly and Company. All rights reserved. Disclaimer | Terms Of Use | Privacy Statement

http://www.lilly.ca/

Business Controller bij Eli Lilly - vacatures - Elsevier.nl

carriere.elsevier.nl

Eli Lilly is een vooraanstaand farmaceutisch bedrijf dat als partner in zorg door innovatieve geneesmiddelen mensen helpt langer, gezonder en actiever te leven. Wereldwijd werken bij deze organisatie meer dan 40.000 mensen verspreid over 140 landen. Vooruitgang en ethiek zijn sleutelbegrippen in de

http://carriere.elsevier.nl/Jobs/12438/Business+Controller+bij+Eli+Lilly.html

Video: Statistical Spotlight - Bottom Fishing - Zibb.com

www.zibb.com

Stocks to Watch - Family Dollar, FPL Group, Eli Lilly, Quest Diagnostics, and Lab Corp of America Holdings (Bloomberg News) http://www.clipsyndicate.com/video/playlist/1998/1112704?cpt=8&wpid=523

http://www.zibb.com/article/5550552/Video+Statistical+Spotlight+Bottom+Fishing

Web Sites powered by Bing

Total : 11,900,000 View more »

Eli Lilly and Company

www.lilly.com

Information for health care professionals, patients, and consumers in the United States only.

http://www.lilly.com/

EDGAR Online

esignal.brand.edgar-online.com

LILLY ELI & CO : 10-Q : 7/31/2009 : 6/30/2009 : People, Glimpse: LILLY ELI & CO : 8-K : 7/22/2009 : 7/22/2009 : People: LILLY ELI & CO : 8-K : 7/14/2009

http://esignal.brand.edgar-online.com/?sym=LLY

News from Zibb.com

Jobs

Business Controller bij Eli Lilly - vacatures - Elsevier.nl

carriere.elsevier.nl

Eli Lilly is een vooraanstaand farmaceutisch bedrijf dat als partner in zorg door innovatieve geneesmiddelen mensen helpt langer, gezonder en actiever te leven. Wereldwijd werken bij deze organisatie meer dan 40.000 mensen verspreid over 140 landen. Vooruitgang en ethiek zijn sleutelbegrippen in de

http://carriere.elsevier.nl/Jobs/JobDetail.aspx?bEmail=true&liJobID=12438

 

Events

Pharmaceutical Event: : PharmiWeb

Navigation [accesskey 1] Content [accesskey 2] Site Search [accesskey 3] Job Seekers Login [accesskey 4] top of page [accesskey 5] PharmiWeb.com, From PharmiWeb Solutions PharmiWeb.com from PharmiWeb Solutions PharmiWeb.com Home Page 19 June 2008 Select a company 1st Pharma People 20:20 Selection

http://www.pharmiweb.com/events/event.asp?eventId=4133&channel=2

EC -

Richard Smith Former President, Strategy Consultant Eli Lilly Asian Operations Mr. Richard Smith is presently a Strategy Consultant on Asia for Eli Lilly and Company. Prior to his current position he was President, Eli Lilly Asian Operations limited based in Hong Kong.

http://www.economistconferences.com/Roundtable/Public/con_common.asp?spkID=8730&rtID=886&area=13&rtRegion=2&pgRegion=&preview=

Pharmaceutical Event: Targeted Oncology Therapeutics : PharmiWeb

Oncology RD is currently booming with pharmaceuticals on a quest to develop effective cancer drugs. The established standard of care – surgery, radiotherapy and chemotherapy is fast giving way to a high-tech array of targeted therapies.

http://www.pharmiweb.com/events/event.asp?eventId=4023&section=howto